193 related articles for article (PubMed ID: 2831374)
1. trans-acting regulation of bovine leukemia virus mRNA processing.
Derse D
J Virol; 1988 Apr; 62(4):1115-9. PubMed ID: 2831374
[TBL] [Abstract][Full Text] [Related]
2. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements.
Derse D
J Virol; 1987 Aug; 61(8):2462-71. PubMed ID: 3037109
[TBL] [Abstract][Full Text] [Related]
3. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
Derse D; Casey JW
Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
[TBL] [Abstract][Full Text] [Related]
4. The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA.
Mamoun RZ; Astier-Gin T; Kettmann R; Deschamps J; Rebeyrotte N; Guillemain BJ
J Virol; 1985 May; 54(2):625-9. PubMed ID: 2985826
[TBL] [Abstract][Full Text] [Related]
5. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
[TBL] [Abstract][Full Text] [Related]
6. Expression of the bovine leukemia virus X region in virus-infected cells.
Rice NR; Simek SL; Dubois GC; Showalter SD; Gilden RV; Stephens RM
J Virol; 1987 May; 61(5):1577-85. PubMed ID: 3033284
[TBL] [Abstract][Full Text] [Related]
7. Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells.
Van den Broeke A; Cleuter Y; Chen G; Portetelle D; Mammerickx M; Zagury D; Fouchard M; Coulombel L; Kettmann R; Burny A
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9263-7. PubMed ID: 2848258
[TBL] [Abstract][Full Text] [Related]
8. Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs.
Durkin K; Rosewick N; Artesi M; Hahaut V; Griebel P; Arsic N; Burny A; Georges M; Van den Broeke A
Retrovirology; 2016 May; 13(1):33. PubMed ID: 27141823
[TBL] [Abstract][Full Text] [Related]
9. Recombinants from a proviral bovine leukemia virus genome corresponding to the 3' region transactivate viral LTR in NIH3T3 and non-infected FLK cells.
Noetzel U; Bauer D; Fischer U; Rosenthal S
Arch Exp Veterinarmed; 1990; 44(6):901-7. PubMed ID: 1966362
[TBL] [Abstract][Full Text] [Related]
10. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
11. Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.
Rosen CA; Sodroski JG; Kettman R; Burny A; Haseltine WA
Science; 1985 Jan; 227(4684):320-2. PubMed ID: 2981432
[TBL] [Abstract][Full Text] [Related]
12. Structure of a defective provirus of bovine leukemia virus.
Ogawa Y; Sagata N; Tsuzuku-Kawamura J; Koyama H; Onuma M; Izawa H; Ikawa Y
Microbiol Immunol; 1987; 31(10):1009-15. PubMed ID: 2828893
[TBL] [Abstract][Full Text] [Related]
13. Two distinct polypeptides may be translated from a single spliced mRNA of the X genes of human T-cell leukemia and bovine leukemia viruses.
Sagata N; Yasunaga T; Ikawa Y
FEBS Lett; 1985 Nov; 192(1):37-42. PubMed ID: 2414130
[TBL] [Abstract][Full Text] [Related]
14. Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex.
Boris-Lawrie K; Temin HM
J Virol; 1995 Mar; 69(3):1920-4. PubMed ID: 7853535
[TBL] [Abstract][Full Text] [Related]
15. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
16. Use of the bovine leukaemia virus LTR U3 promoter for expressing antisense antiviral RNAs and competitive inhibition of viral infection in cell culture.
Shayakhmetov D; Kovalenko D; Yurov G; Borisenko A; Tikchonenko T
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1941-8. PubMed ID: 9266992
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide sequence and structure of integrated bovine leukemia virus long terminal repeats.
Derse D; Diniak AJ; Casey JW; Deininger PL
Virology; 1985 Feb; 141(1):162-6. PubMed ID: 2983496
[TBL] [Abstract][Full Text] [Related]
18. The structure of cloned 3'-terminal RNA region of bovine leukemia virus (BLV).
Tsimanis A; Bichko V; Dreilina D; Meldrais J; Lozha V; Kukaine R; Gren E
Nucleic Acids Res; 1983 Sep; 11(17):6079-87. PubMed ID: 6310526
[TBL] [Abstract][Full Text] [Related]
19. Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences.
Kettmann R; Deschamps J; Cleuter Y; Couez D; Burny A; Marbaix G
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2465-9. PubMed ID: 6283527
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel singly spliced pX mRNA transcripts common to all human T-cell leukemia virus type 1-related retroviruses.
Orita S; Sato S; Aono Y; Minoura N; Yamashita T; Hinuma Y; Igarashi H
Virus Genes; 1993 Jun; 7(2):197-204. PubMed ID: 8396285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
